Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Transplantation Proceedings
|
April 1, 1996
Human decay accelerating factor successfully protects pig hearts from hyperacute rejection by human blood
M Schmoeckel, G Nollert, M Shahmohammadi, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|
July 10, 2007
Successful pulmonary thromboendarterectomy for right atrial thrombosis in a heart transplant recipient: a case report
A K Bigdeli, A Beiras-Fernandez, I Kaczmarek, et al.
Psychological Medicine
|
August 21, 2009
A beta-adrenergic antagonist reduces traumatic memories and PTSD symptoms in female but not in male patients after cardiac surgery
T Krauseneck, F Padberg, B Roozendaal, et al.
Transplantation Proceedings
|
March 20, 1999
Splenectomy improves survival of HDAF transgenic pig kidneys in primates
M Schmoeckel, F N Bhatti, A Zaidi, et al.
Transplantation Proceedings
|
September 2, 1998
Survival of life-supporting HDAF transgenic kidneys in primates is enhanced by splenectomy
F N Bhatti, A Zaidi, M Schmoeckel, et al.
Transplantation Proceedings
|
November 20, 1997
Xenotransplantation of pig organs transgenic for human DAF: an update
M Schmoeckel, F N Bhatti, A Zaidi, et al.
Der Anaesthesist
|
November 12, 2010
[Caspofungin after solid organ transplantation in Germany: observational study on treatment of invasive fungal infections]
C Lichtenstern, J Pratschke, U Schulz, et al.
Transplantation Proceedings
|
February 1, 1994
Antimyosin scintigraphy after orthotopic heart transplantation in children
U Brandl, H Reichenspurner, A Schütz, et al.
Transplantation Proceedings
|
March 20, 1999
Three-month survival of HDAFF transgenic pig hearts transplanted into primates
F N Bhatti, M Schmoeckel, A Zaidi, et al.
Transplantation Proceedings
|
April 6, 2005
Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model
U Brandl, M Erhardt, H Joeckle, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Transplantation Proceedings
|
April 1, 1996
Human decay accelerating factor successfully protects pig hearts from hyperacute rejection by human blood
M Schmoeckel, G Nollert, M Shahmohammadi, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|
July 10, 2007
Successful pulmonary thromboendarterectomy for right atrial thrombosis in a heart transplant recipient: a case report
A K Bigdeli, A Beiras-Fernandez, I Kaczmarek, et al.
Psychological Medicine
|
August 21, 2009
A beta-adrenergic antagonist reduces traumatic memories and PTSD symptoms in female but not in male patients after cardiac surgery
T Krauseneck, F Padberg, B Roozendaal, et al.
Transplantation Proceedings
|
March 20, 1999
Splenectomy improves survival of HDAF transgenic pig kidneys in primates
M Schmoeckel, F N Bhatti, A Zaidi, et al.
Transplantation Proceedings
|
September 2, 1998
Survival of life-supporting HDAF transgenic kidneys in primates is enhanced by splenectomy
F N Bhatti, A Zaidi, M Schmoeckel, et al.
Transplantation Proceedings
|
November 20, 1997
Xenotransplantation of pig organs transgenic for human DAF: an update
M Schmoeckel, F N Bhatti, A Zaidi, et al.
Der Anaesthesist
|
November 12, 2010
[Caspofungin after solid organ transplantation in Germany: observational study on treatment of invasive fungal infections]
C Lichtenstern, J Pratschke, U Schulz, et al.
Transplantation Proceedings
|
February 1, 1994
Antimyosin scintigraphy after orthotopic heart transplantation in children
U Brandl, H Reichenspurner, A Schütz, et al.
Transplantation Proceedings
|
March 20, 1999
Three-month survival of HDAFF transgenic pig hearts transplanted into primates
F N Bhatti, M Schmoeckel, A Zaidi, et al.
Transplantation Proceedings
|
April 6, 2005
Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model
U Brandl, M Erhardt, H Joeckle, et al.
Page
of 6